Antibacterial Drug Discovery and Development Summit - Tenth Annual SRI Summit.
Lynch
A Simon
AS
Cumbre Inc, Dallas, TX 75235-2304, USA. simon.lynch@cumbre.net
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D018441:Biofilms / Q000187:drug effects / Q000254:growth & development; D015780:Carbapenems / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D000077726:Doripenem; D015195:Drug Design; D004352:Drug Resistance, Microbial; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006801:Humans; D007472:Iohexol / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D018942:Macrolides / Q000737:chemistry / Q000627:therapeutic use; D008861:Microsomes / Q000187:drug effects / Q000378:metabolism; D008911:Minocycline / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D013678:Technology, Pharmaceutical / Q000379:methods* / Q000639:trends; D000078304:Tigecycline
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D018942:Macrolides; C509466:VIC-105555; D007472:Iohexol; D000078304:Tigecycline; C036778:iogulamide; D000077726:Doripenem; D008911:Minocycline